In Reply

ABSTRACT: The author responds to comments on the study published by Ravaud et al. in The Oncologist on sunitinib for medullary thyroid carcinoma.

SUBMITTER: Bugalho M 

PROVIDER: S-EPMC3227934 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature